Cargando…
A Potential Alternative Orodispersible Formulation to Prednisolone Sodium Phosphate Orally Disintegrating Tablets
The orally disintegrating tablet (ODT) has shown vast potential as an alternative oral dosage form to conventional tablets wherein they can disintegrate rapidly (≤30 s) upon contact with saliva fluid and should have an acceptable mouthfeel as long as their weight doesn’t exceed 500 mg. However, owin...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832848/ https://www.ncbi.nlm.nih.gov/pubmed/33477855 http://dx.doi.org/10.3390/pharmaceutics13010120 |
_version_ | 1783641926358007808 |
---|---|
author | Tawfik, Essam A. Scarpa, Mariagiovanna Abdelhakim, Hend E. Bukhary, Haitham A. Craig, Duncan Q. M. Barker, Susan A. Orlu, Mine |
author_facet | Tawfik, Essam A. Scarpa, Mariagiovanna Abdelhakim, Hend E. Bukhary, Haitham A. Craig, Duncan Q. M. Barker, Susan A. Orlu, Mine |
author_sort | Tawfik, Essam A. |
collection | PubMed |
description | The orally disintegrating tablet (ODT) has shown vast potential as an alternative oral dosage form to conventional tablets wherein they can disintegrate rapidly (≤30 s) upon contact with saliva fluid and should have an acceptable mouthfeel as long as their weight doesn’t exceed 500 mg. However, owing to the bitterness of several active ingredients, there is a need to find a suitable alternative to ODTs that maintains their features and can be taste-masked more simply and inexpensively. Therefore, electrospun nanofibers and solvent-cast oral dispersible films (ODFs) are used in this study as potential OD formulations for prednisolone sodium phosphate (PSP) that is commercially available as ODTs. The encapsulation efficiency (EE%) of the ODFs was higher (≈100%) compared to the nanofibers (≈87%), while the disintegration time was considerably faster for the electrospun nanofibers (≈30 s) than the solvent-cast ODFs (≈700 s). Hence, accelerated release rate of PSP from the nanofibers was obtained, due to their higher surface area and characteristic surface morphology that permitted higher wettability and thus, faster erosion. Taste-assessment study using the electronic-tongue quantified the bitterness threshold of the drug and its aversiveness concentration (2.79 mM). Therefore, a taste-masking strategy would be useful when further formulating PSP as an OD formulation. |
format | Online Article Text |
id | pubmed-7832848 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-78328482021-01-26 A Potential Alternative Orodispersible Formulation to Prednisolone Sodium Phosphate Orally Disintegrating Tablets Tawfik, Essam A. Scarpa, Mariagiovanna Abdelhakim, Hend E. Bukhary, Haitham A. Craig, Duncan Q. M. Barker, Susan A. Orlu, Mine Pharmaceutics Article The orally disintegrating tablet (ODT) has shown vast potential as an alternative oral dosage form to conventional tablets wherein they can disintegrate rapidly (≤30 s) upon contact with saliva fluid and should have an acceptable mouthfeel as long as their weight doesn’t exceed 500 mg. However, owing to the bitterness of several active ingredients, there is a need to find a suitable alternative to ODTs that maintains their features and can be taste-masked more simply and inexpensively. Therefore, electrospun nanofibers and solvent-cast oral dispersible films (ODFs) are used in this study as potential OD formulations for prednisolone sodium phosphate (PSP) that is commercially available as ODTs. The encapsulation efficiency (EE%) of the ODFs was higher (≈100%) compared to the nanofibers (≈87%), while the disintegration time was considerably faster for the electrospun nanofibers (≈30 s) than the solvent-cast ODFs (≈700 s). Hence, accelerated release rate of PSP from the nanofibers was obtained, due to their higher surface area and characteristic surface morphology that permitted higher wettability and thus, faster erosion. Taste-assessment study using the electronic-tongue quantified the bitterness threshold of the drug and its aversiveness concentration (2.79 mM). Therefore, a taste-masking strategy would be useful when further formulating PSP as an OD formulation. MDPI 2021-01-19 /pmc/articles/PMC7832848/ /pubmed/33477855 http://dx.doi.org/10.3390/pharmaceutics13010120 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Tawfik, Essam A. Scarpa, Mariagiovanna Abdelhakim, Hend E. Bukhary, Haitham A. Craig, Duncan Q. M. Barker, Susan A. Orlu, Mine A Potential Alternative Orodispersible Formulation to Prednisolone Sodium Phosphate Orally Disintegrating Tablets |
title | A Potential Alternative Orodispersible Formulation to Prednisolone Sodium Phosphate Orally Disintegrating Tablets |
title_full | A Potential Alternative Orodispersible Formulation to Prednisolone Sodium Phosphate Orally Disintegrating Tablets |
title_fullStr | A Potential Alternative Orodispersible Formulation to Prednisolone Sodium Phosphate Orally Disintegrating Tablets |
title_full_unstemmed | A Potential Alternative Orodispersible Formulation to Prednisolone Sodium Phosphate Orally Disintegrating Tablets |
title_short | A Potential Alternative Orodispersible Formulation to Prednisolone Sodium Phosphate Orally Disintegrating Tablets |
title_sort | potential alternative orodispersible formulation to prednisolone sodium phosphate orally disintegrating tablets |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832848/ https://www.ncbi.nlm.nih.gov/pubmed/33477855 http://dx.doi.org/10.3390/pharmaceutics13010120 |
work_keys_str_mv | AT tawfikessama apotentialalternativeorodispersibleformulationtoprednisolonesodiumphosphateorallydisintegratingtablets AT scarpamariagiovanna apotentialalternativeorodispersibleformulationtoprednisolonesodiumphosphateorallydisintegratingtablets AT abdelhakimhende apotentialalternativeorodispersibleformulationtoprednisolonesodiumphosphateorallydisintegratingtablets AT bukharyhaithama apotentialalternativeorodispersibleformulationtoprednisolonesodiumphosphateorallydisintegratingtablets AT craigduncanqm apotentialalternativeorodispersibleformulationtoprednisolonesodiumphosphateorallydisintegratingtablets AT barkersusana apotentialalternativeorodispersibleformulationtoprednisolonesodiumphosphateorallydisintegratingtablets AT orlumine apotentialalternativeorodispersibleformulationtoprednisolonesodiumphosphateorallydisintegratingtablets AT tawfikessama potentialalternativeorodispersibleformulationtoprednisolonesodiumphosphateorallydisintegratingtablets AT scarpamariagiovanna potentialalternativeorodispersibleformulationtoprednisolonesodiumphosphateorallydisintegratingtablets AT abdelhakimhende potentialalternativeorodispersibleformulationtoprednisolonesodiumphosphateorallydisintegratingtablets AT bukharyhaithama potentialalternativeorodispersibleformulationtoprednisolonesodiumphosphateorallydisintegratingtablets AT craigduncanqm potentialalternativeorodispersibleformulationtoprednisolonesodiumphosphateorallydisintegratingtablets AT barkersusana potentialalternativeorodispersibleformulationtoprednisolonesodiumphosphateorallydisintegratingtablets AT orlumine potentialalternativeorodispersibleformulationtoprednisolonesodiumphosphateorallydisintegratingtablets |